NASDAQ NMS - GLOBAL MARKET · GNLX
-0.73% · -$0.0200 · Vol 223.7K
Market closed · last close 4:00 PM ET · price as of 16:55:03 ET
Genelux Corp

Genelux Corp

Biotechnology
$2.72
Card
Relationship Map

Veridion Score

BETALOW CONF · 5/6 factorsMethodology
Sentiment absence reason unknown
GNLX
Genelux Corp
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

56/ 100
Veridion Score
NEUTRAL · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 5/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is GNLX moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading GNLX catalysts
About Genelux Corp
PHARMACEUTICAL PREPARATIONS
Listed since
2023
Employees
26
Country
US

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.78
Day high
$2.81
Day low
$2.68
Previous close
$2.74
52W high
$8.24
-66.99% from high
52W low
$2.30
7% of range
Market cap
$123.1M
EPS
$-0.8200
Beta
1.43
Shares out
45.2M
Volume
223.7K
0.82× rel vol
Avg volume
272K
VWAP
$2.72
Price history computed in-house
1W
+0.74%
1M
-5.88%
3M
-9.63%
1Y
-28.04%
YTD
-37.61%
SMA 50 $2.86 · below
SMA 200 $3.23 · below
52W position 7%

GNLX overview

Veridion Score
56
Registered · 2026-08-21
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around GNLX.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading GNLX Form 4 filings
Public disclosures

Congress activity in GNLX

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for GNLX in the cached public ledger.

Federal contracts

GNLX contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for GNLX in this window.
Lobbying spend

GNLX lobbying filings, year to date.

Registered lobbying filings matched to Genelux Corp.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for GNLX in this window.
Loading news for GNLX
Analyst ratings
Sovereign unlock shows live analyst consensus for GNLX.
Options
Sovereign unlock shows live options positioning for GNLX.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.